DANIEL KELLUM: Open Payments
NPI 1205820990 · SCHERTZ, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 130 payments from 22 companies in 2025. Trend: 2023 $3,175 · 2024 $1,998 · 2025 $1,789
Food & beverage: $1,789
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $556 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $221 |
| Amgen Inc. | 17 | $186 |
| PFIZER INC. | 25 | $179 |
| INTUITIVE SURGICAL, INC. | 1 | $111 |
| Corcept Therapeutics | 4 | $70 |
| SANOFI-AVENTIS U.S. LLC | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Dexcom, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: VRAYLAR, Kerendia, NURTEC ODT, OTEZLA, Da Vinci Surgical System, QULIPTA, UBRELVY, Korlym.
Industry payments across TX — which companies pay providers there.
